In this study, typical cases of coronary heart disease are selected. They will be intervened by Xuesaitong soft capsules to investigate efficacy and safety for Coronary Heart disease.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Enrollment
70
Panax Notoginseng Saponins, Specification:0.33 per bag, once take two pills and twice a day during a month.
Xuesaitong soft capsule Placebo, soft capsule, once take two pills and twice a day during a month.
Guang Anmen Hospital
Beijing, Beijing Municipality, China
RECRUITINGmajor adverse cardiovascular events
death, myocardial infarction, hospitalization for unstable angina or stroke
Time frame: 60 days
Seattle Angina Questionnaire
to evaluate patients by Seattle Angina Questionnaire
Time frame: 60 days
blood stasis syndrome scale of Coronary heart disease angina pectoris
to evaluate patients by blood stasis syndrome scale of Coronary heart disease angina pectoris
Time frame: 60
lipid
Triacylglyceride,total cholesterol, low densith lipoprotein, high densith lipoprotein
Time frame: 60
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.